ID   WA09
AC   CVCL_9773
SY   WA 09; WA-09; WA9; H9; H9.hESCs; H9 ESC; H9 hES; H9ES; GE09; WAe003-A; WICELLe003-A; WAe009-A; WA09-PCBC; PCBC02hse2014030502; SC14-067; UKERe008-A
DR   BTO; BTO_0006062
DR   CLO; CLO_0037313
DR   4DN; 4DNSR9WBB58Z
DR   BioGRID_ORCS_Cell_line; 1321
DR   BioSample; SAMN03471903
DR   BioSamples; SAMEA7769668
DR   CCRID; 3101HUMSCSP302
DR   CCRID; 3101HUMSCSP307
DR   ENCODE; ENCBS013BRF
DR   ENCODE; ENCBS061KRP
DR   ENCODE; ENCBS113LZP
DR   ENCODE; ENCBS140HIH
DR   ENCODE; ENCBS156LDX
DR   ENCODE; ENCBS220TZB
DR   ENCODE; ENCBS277KDR
DR   ENCODE; ENCBS298AAA
DR   ENCODE; ENCBS299AAA
DR   ENCODE; ENCBS300AAA
DR   ENCODE; ENCBS315DEY
DR   ENCODE; ENCBS375GFI
DR   ENCODE; ENCBS377MXB
DR   ENCODE; ENCBS399JWQ
DR   ENCODE; ENCBS410BMR
DR   ENCODE; ENCBS417MAQ
DR   ENCODE; ENCBS477SFO
DR   ENCODE; ENCBS485PGF
DR   ENCODE; ENCBS532LWE
DR   ENCODE; ENCBS616QKE
DR   ENCODE; ENCBS656LSW
DR   ENCODE; ENCBS692FVF
DR   ENCODE; ENCBS703ZDS
DR   ENCODE; ENCBS741LLD
DR   ENCODE; ENCBS757OPX
DR   ENCODE; ENCBS769EPD
DR   ENCODE; ENCBS808UWK
DR   ENCODE; ENCBS853WXF
DR   ENCODE; ENCBS883RFB
DR   ENCODE; ENCBS996IWU
DR   GEO; GSM239975
DR   GEO; GSM288333
DR   GEO; GSM288335
DR   GEO; GSM288397
DR   GEO; GSM347923
DR   GEO; GSM383878
DR   GEO; GSM383879
DR   GEO; GSM384100
DR   GEO; GSM500936
DR   GEO; GSM569191
DR   GEO; GSM569192
DR   GEO; GSM579901
DR   GEO; GSM579902
DR   GEO; GSM603054
DR   GEO; GSM603055
DR   GEO; GSM605307
DR   GEO; GSM605310
DR   GEO; GSM605314
DR   GEO; GSM605316
DR   GEO; GSM605324
DR   GEO; GSM616127
DR   GEO; GSM616128
DR   GEO; GSM616129
DR   GEO; GSM627785
DR   GEO; GSM637777
DR   GEO; GSM665037
DR   GEO; GSM667608
DR   GEO; GSM667609
DR   GEO; GSM667610
DR   GEO; GSM667611
DR   GEO; GSM667612
DR   GEO; GSM667613
DR   GEO; GSM667616
DR   GEO; GSM667619
DR   GEO; GSM667620
DR   GEO; GSM667621
DR   GEO; GSM667622
DR   GEO; GSM667623
DR   GEO; GSM667625
DR   GEO; GSM667626
DR   GEO; GSM667628
DR   GEO; GSM667629
DR   GEO; GSM667630
DR   GEO; GSM667631
DR   GEO; GSM667632
DR   GEO; GSM667633
DR   GEO; GSM667634
DR   GEO; GSM667635
DR   GEO; GSM667636
DR   GEO; GSM667637
DR   GEO; GSM667638
DR   GEO; GSM667639
DR   GEO; GSM667640
DR   GEO; GSM667643
DR   GEO; GSM669899
DR   GEO; GSM669901
DR   GEO; GSM670053
DR   GEO; GSM674603
DR   GEO; GSM706044
DR   GEO; GSM706059
DR   GEO; GSM706060
DR   GEO; GSM706061
DR   GEO; GSM706062
DR   GEO; GSM706063
DR   GEO; GSM706064
DR   GEO; GSM706066
DR   GEO; GSM706071
DR   GEO; GSM706076
DR   GEO; GSM755488
DR   GEO; GSM755491
DR   GEO; GSM816629
DR   GEO; GSM856731
DR   GEO; GSM860961
DR   GEO; GSM860962
DR   GEO; GSM860963
DR   GEO; GSM862733
DR   GEO; GSM927236
DR   GEO; GSM997555
DR   GEO; GSM997556
DR   GEO; GSM997557
DR   GEO; GSM1040243
DR   GEO; GSM1040313
DR   GEO; GSM1084832
DR   GEO; GSM1084835
DR   GEO; GSM1084943
DR   GEO; GSM1084944
DR   GEO; GSM1084992
DR   GEO; GSM1085015
DR   GEO; GSM1215278
DR   GEO; GSM1215279
DR   GEO; GSM1227088
DR   GEO; GSM1489249
DR   GEO; GSM1489460
DR   GEO; GSM1589800
DR   GEO; GSM1589812
DR   GEO; GSM1589932
DR   GEO; GSM1589944
DR   GEO; GSM1658377
DR   hPSCreg; WAe009-A
DR   IGRhCellID; H9%20p25-2
DR   IGRhCellID; H9%20p34
DR   LINCS_LDP; ES-1001
DR   NIHhESC; NIHhESC-10-0062
DR   PRIDE; PXD003903
DR   PRIDE; PXD006271
DR   SKIP; SKIP001452
DR   SKIP; SKIP001935
DR   TOKU-E; 4223
DR   WiCell; wa09
DR   WiCell; wa09-cgmp-material
DR   WiCell; wa09-matched-research
DR   WiCell; wa09-pcbc
DR   Wikidata; Q27555433
RX   PubMed=9804556;
RX   PubMed=14745950;
RX   PubMed=16388305;
RX   PubMed=16919167;
RX   PubMed=17570852;
RX   PubMed=17572666;
RX   PubMed=20641038;
RX   PubMed=20736931;
RX   PubMed=21295703;
RX   PubMed=21936705;
RX   PubMed=21983960;
RX   PubMed=22514597;
RX   PubMed=22802639;
RX   PubMed=23117585;
RX   PubMed=24259714;
RX   PubMed=27293150;
RX   PubMed=27476965;
RX   PubMed=27688775;
RX   PubMed=28435121;
RX   PubMed=28445466;
RX   PubMed=28664172;
RX   PubMed=29246576;
RX   PubMed=29861859;
RX   PubMed=30388422;
RX   PubMed=35805069;
WW   Info; -; -; https://news.wisc.edu/nih-reapproves-wicells-h9-and-three-other-wisconsin-stem-cell-lines-for-federally-funded-research/
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/BG02ES_and_H9ES_Myers_protocols.pdf
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/13
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=88
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0062.
CC   Registration: Swiss research registry; BAG-hES-IMP-0016.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18/SCSC11-06.
CC   HLA typing: A*02:03; B*35,44; C*04,07; DQB1*05,06; DRB1*15,16:01; DRB5*01 (PubMed=16919167).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151Ser (c.451C>T); ClinVar=VCV000012370; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181His (c.542G>A); ClinVar=VCV000142320; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Trp (c.799C>T); ClinVar=VCV000141764; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Omics: Genomics; ChIP-seq; H2AK5ac.
CC   Omics: Genomics; ChIP-seq; H2BK12ac.
CC   Omics: Genomics; ChIP-seq; H2BK15ac.
CC   Omics: Genomics; ChIP-seq; H2BK5ac.
CC   Omics: Genomics; ChIP-seq; H3K18ac.
CC   Omics: Genomics; ChIP-seq; H3K23ac.
CC   Omics: Genomics; ChIP-seq; H3K23me2.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me2.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K56ac.
CC   Omics: Genomics; ChIP-seq; H3K79me1.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K20me1.
CC   Omics: Genomics; ChIP-seq; H4K5ac.
CC   Omics: Genomics; ChIP-seq; H4K8ac.
CC   Omics: Genomics; ChIP-seq; H4K91ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Subcellular; Mitochondrion.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Anecdotal: WA01, WA07, WA09, WA13 and WA14 were the first human embryonic stem cells to be established.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=16919167; PubMed=29246576; WiCell=wa09
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 13
ST   D19S433: 12,15
ST   D21S11: 30
ST   D2S1338: 18,24
ST   D3S1358: 13,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 8,14
ST   FGA: 26,28
ST   Penta D: 9,13
ST   Penta E: 11,14
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 41
//
RX   PubMed=9804556; DOI=10.1126/science.282.5391.1145;
RA   Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A.,
RA   Swiergiel J.J., Marshall V.S., Jones J.M.;
RT   "Embryonic stem cell lines derived from human blastocysts.";
RL   Science 282:1145-1147(1998).
//
RX   PubMed=14745950; DOI=10.1002/dvdy.10431;
RA   Carpenter M.K., Rosler E.S., Fisk G.J., Brandenberger R., Ares X.,
RA   Miura T., Lucero M.T., Rao M.S.;
RT   "Properties of four human embryonic stem cell lines maintained in a
RT   feeder-free culture system.";
RL   Dev. Dyn. 229:243-258(2004).
//
RX   PubMed=16388305; DOI=10.1038/nbt1177;
RA   Ludwig T.E., Levenstein M.E., Jones J.M., Berggren W.T., Mitchen E.R.,
RA   Frane J.L., Crandall L.J., Daigh C.A., Conard K.R., Piekarczyk M.S.,
RA   Llanas R.A., Thomson J.A.;
RT   "Derivation of human embryonic stem cells in defined conditions.";
RL   Nat. Biotechnol. 24:185-187(2006).
//
RX   PubMed=16919167; DOI=10.1186/1741-7007-4-28; PMCID=PMC1601965;
RA   Josephson R., Sykes G.R., Liu Y., Ording C.J., Xu W.-N., Zeng X.-M.,
RA   Shin S., Loring J.F., Maitra A., Rao M.S., Auerbach J.M.;
RT   "A molecular scheme for improved characterization of human embryonic
RT   stem cell lines.";
RL   BMC Biol. 4:28.1-28.13(2006).
//
RX   PubMed=17570852; DOI=10.1186/gb-2007-8-6-r113; PMCID=PMC2394759;
RA   Hirst M., Delaney A., Rogers S.A., Schnerch A., Persaud D.R.,
RA   O'Connor M.D., Zeng T., Moksa M., Fichter K., Mah D., Go A.,
RA   Morin R.D., Baross A., Zhao Y.-J., Khattra J., Prabhu A.-L., Pandoh P.,
RA   McDonald H., Asano J.K., Dhalla N., Ma K., Lee S., Ally A., Chahal N.,
RA   Menzies S., Siddiqui A., Holt R.A., Jones S.J.M., Gerhard D.S.,
RA   Thomson J.A., Eaves C.J., Marra M.A.;
RT   "LongSAGE profiling of nine human embryonic stem cell lines.";
RL   Genome Biol. 8:R113.1-R113.12(2007).
//
RX   PubMed=17572666; DOI=10.1038/nbt1318;
RA   Adewumi O., Aflatoonian B., Ahrlund-Richter L., Amit M., Andrews P.W.,
RA   Beighton G., Bello P.A., Benvenisty N., Berry L.S., Bevan S., Blum B.,
RA   Brooking J., Chen K.G., Choo A.B.-H., Churchill G.A., Corbel M.,
RA   Damjanov I., Draper J.S., Dvorak P., Emanuelsson K., Fleck R.A.,
RA   Ford A., Gertow K., Gertsenstein M., Gokhale P.J., Hamilton R.S.,
RA   Hampl A., Healy L.E., Hovatta O., Hyllner J., Imreh M.P.,
RA   Itskovitz-Eldor J., Jackson J., Johnson J.L., Jones M., Kee K.,
RA   King B.L., Knowles B.B., Lako M., Lebrin F., Mallon B.S., Manning D.,
RA   Mayshar Y., McKay R.D.G., Michalska A.E., Mikkola M., Mileikovsky M.,
RA   Minger S.L., Moore H.D., Mummery C.L., Nagy A., Nakatsuji N.,
RA   O'Brien C.M., Oh S.K.-W., Olsson C., Otonkoski T., Park K.-Y.,
RA   Passier R., Patel H., Patel M.J., Pedersen R., Pera M.F.,
RA   Piekarczyk M.S., Reijo Pera R.A., Reubinoff B.E., Robins A.J.,
RA   Rossant J., Rugg-Gunn P., Schulz T.C., Semb H., Sherrer E.S., Siemen H.,
RA   Stacey G.N., Stojkovic M., Suemori H., Szatkiewicz J., Turetsky T.T.,
RA   Tuuri T., van den Brink S., Vintersten K., Vuoristo S.,
RA   Ward-van Oostwaard D., Weaver T.A., Young L.A., Zhang W.-D.;
RG   International Stem Cell Initiative;
RT   "Characterization of human embryonic stem cell lines by the
RT   International Stem Cell Initiative.";
RL   Nat. Biotechnol. 25:803-816(2007).
//
RX   PubMed=20641038; DOI=10.1002/stem.471; PMCID=PMC2996086;
RA   Gutierrez-Aranda I., Ramos-Mejia V., Bueno C., Munoz-Lopez M.,
RA   Real P.J., Macia A., Sanchez L., Ligero G., Garcia-Parez J.L.,
RA   Menendez P.;
RT   "Human induced pluripotent stem cells develop teratoma more
RT   efficiently and faster than human embryonic stem cells regardless the
RT   site of injection.";
RL   Stem Cells 28:1568-1570(2010).
//
RX   PubMed=20736931; DOI=10.1038/mt.2010.179; PMCID=PMC2997587;
RA   Ramos-Mejia V., Melen Frajlich G.J., Sanchez L., Gutierrez-Aranda I.,
RA   Ligero G., Cortes J.L., Real P.J., Bueno C., Menendez P.;
RT   "Nodal/activin signaling predicts human pluripotent stem cell lines
RT   prone to differentiate toward the hematopoietic lineage.";
RL   Mol. Ther. 18:2173-2181(2010).
//
RX   PubMed=21295703; DOI=10.1016/j.cell.2010.12.032; PMCID=PMC3063454;
RA   Bock C., Kiskinis E., Verstappen G., Gu H.-C., Boulting G.L., Smith Z.D.,
RA   Ziller M.J., Croft G.F., Amoroso M.W., Oakley D.H., Gnirke A.,
RA   Eggan K.C., Meissner A.;
RT   "Reference maps of human ES and iPS cell variation enable
RT   high-throughput characterization of pluripotent cell lines.";
RL   Cell 144:439-452(2011).
//
RX   PubMed=21936705; DOI=10.1089/scd.2011.0400;
RA   Ramos-Mejia V., Fernandez A.F., Ayllon V., Real P.J., Bueno C.,
RA   Anderson P., Martin F., Fraga M.F., Menendez P.;
RT   "Maintenance of human embryonic stem cells in mesenchymal stem
RT   cell-conditioned media augments hematopoietic specification.";
RL   Stem Cells Dev. 21:1549-1558(2012).
//
RX   PubMed=21983960; DOI=10.1038/nmeth.1699; PMCID=PMC3432645;
RA   Phanstiel D.H., Brumbaugh J., Wenger C.D., Tian S.-L., Probasco M.D.,
RA   Bailey D.J., Swaney D.L., Tervo M.A., Bolin J.M., Ruotti V.,
RA   Stewart R., Thomson J.A., Coon J.J.;
RT   "Proteomic and phosphoproteomic comparison of human ES and iPS
RT   cells.";
RL   Nat. Methods 8:821-827(2011).
//
RX   PubMed=22514597; DOI=10.1371/journal.pone.0030743; PMCID=PMC3326006;
RA   Sandt C., Feraud O., Oudrhiri N., Bonnet M.-L., Meunier M.-C.,
RA   Valogne Y., Bertrand A., Raphael M., Griscelli F., Turhan A.G.,
RA   Dumas P., Bennaceur-Griscelli A.;
RT   "Identification of spectral modifications occurring during
RT   reprogramming of somatic cells.";
RL   PLoS ONE 7:e30743.1-e30743.7(2012).
//
RX   PubMed=22802639; DOI=10.1073/pnas.1209979109; PMCID=PMC3411998;
RA   Kajiwara M., Aoi T., Okita K., Takahashi R., Inoue H., Takayama N.,
RA   Endo H., Eto K., Toguchida J., Uemoto S., Yamanaka S.;
RT   "Donor-dependent variations in hepatic differentiation from
RT   human-induced pluripotent stem cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12538-12543(2012).
//
RX   PubMed=23117585; DOI=10.1016/j.scr.2012.09.002; PMCID=PMC3590800;
RA   Mallon B.S., Chenoweth J.G., Johnson K.R., Hamilton R.S., Tesar P.J.,
RA   Yavatkar A.S., Tyson L.J., Park K., Chen K.G., Fann Y.-C., McKay R.D.G.;
RT   "StemCellDB: the human pluripotent stem cell database at the National
RT   Institutes of Health.";
RL   Stem Cell Res. 10:57-66(2013).
//
RX   PubMed=24259714; DOI=10.1073/pnas.1319061110; PMCID=PMC3870695;
RA   Koyanagi-Aoi M., Ohnuki M., Takahashi K., Okita K., Noma H.,
RA   Sawamura Y., Teramoto I., Narita M., Sato Y., Ichisaka T., Amano N.,
RA   Watanabe A., Morizane A., Yamada Y., Sato T., Takahashi J.,
RA   Yamanaka S.;
RT   "Differentiation-defective phenotypes revealed by large-scale analyses
RT   of human pluripotent stem cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:20569-20574(2013).
//
RX   PubMed=27293150; DOI=10.1016/j.stemcr.2016.05.006; PMCID=PMC4944587;
RA   Salomonis N., Dexheimer P.J., Omberg L., Schroll R., Bush S., Huo J.S.,
RA   Schriml L.M., Sui S.H., Keddache M., Mayhew C.N., Shanmukhappa S.K.,
RA   Wells J.M., Daily K., Hubler S., Wang Y.-L., Zambidis E.T., Margolin A.A.,
RA   Hide W.A., Hatzopoulos A.K., Malik P., Cancelas J.A., Aronow B.J.,
RA   Lutzko C.;
RT   "Integrated genomic analysis of diverse induced pluripotent stem cells
RT   from the Progenitor Cell Biology Consortium.";
RL   Stem Cell Reports 7:110-125(2016).
//
RX   PubMed=27476965; DOI=10.1016/j.stem.2016.06.019;
RA   Nishizawa M., Chonabayashi K., Nomura M., Tanaka A., Nakamura M.,
RA   Inagaki A., Nishikawa M., Takei I., Oishi A., Tanabe K., Ohnuki M.,
RA   Yokota H., Koyanagi-Aoi M., Okita K., Watanabe A., Takaori-Kondo A.,
RA   Yamanaka S., Yoshida Y.;
RT   "Epigenetic variation between human induced pluripotent stem cell
RT   lines is an indicator of differentiation capacity.";
RL   Cell Stem Cell 19:341-354(2016).
//
RX   PubMed=27688775; DOI=10.1155/2016/3826249; PMCID=PMC5023833;
RA   Nagaria P.K., Robert C., Park T.S., Huo J.S., Zambidis E.T.,
RA   Rassool F.V.;
RT   "High-fidelity reprogrammed human IPSCs have a high efficacy of DNA
RT   repair and resemble hESCs in their MYC transcriptional signature.";
RL   Stem Cells Int. 2016:3826249.1-3826249.14(2016).
//
RX   PubMed=28435121; DOI=10.1016/j.jprot.2017.04.017;
RA   Shekari F., Nezari H., Larijani M.R., Han C.-L., Baharvand H.,
RA   Chen Y.-J., Salekdeh G.H.;
RT   "Proteome analysis of human embryonic stem cells organelles.";
RL   J. Proteomics 162:108-118(2017).
//
RX   PubMed=28445466; DOI=10.1038/nature22312; PMCID=PMC5427175;
RA   Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C.,
RA   Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G.,
RA   Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A.,
RA   Eggan K.C.;
RT   "Human pluripotent stem cells recurrently acquire and expand dominant
RT   negative p53 mutations.";
RL   Nature 545:229-233(2017).
//
RX   PubMed=28664172; DOI=10.1016/j.dib.2017.05.036; PMCID=PMC5480819;
RA   Shekari F., Nezari H., Chen Y.-J., Baharvand H., Salekdeh G.H.;
RT   "Data for whole and mitochondrial proteome of human embryonic stem
RT   cells.";
RL   Data Brief 13:371-376(2017).
//
RX   PubMed=29246576; DOI=10.1016/j.scr.2017.08.004;
RA   Domingo-Reines J., Lopez-Ornelas A., Montes R., Romero T.,
RA   Rodriguez-Llamas J.L., Lara-Rodarte R., Gonzalez-Pozas F., Ayllon V.,
RA   Menendez P., Velasco I., Ramos-Mejia V.;
RT   "Hoxa9 and EGFP reporter expression in human embryonic stem cells
RT   (hESC) as useful tools for studying human development.";
RL   Stem Cell Res. 25:286-290(2017).
//
RX   PubMed=29861859; DOI=10.18632/oncotarget.25353; PMCID=PMC5982739;
RA   Panova A.V., Bogomazova A.N., Lagarkova M.A., Kiselev S.L.;
RT   "Epigenetic reprogramming by naive conditions establishes an
RT   irreversible state of partial X chromosome reactivation in female stem
RT   cells.";
RL   Oncotarget 9:25136-25147(2018).
//
RX   PubMed=30388422; DOI=10.1016/j.stem.2018.10.009;
RA   Ludwig T.E., Kujak A., Rauti A., Andrzejewski S., Langbehn S.,
RA   Mayfield J., Fuller J., Yashiro Y., Hara Y., Bhattacharyya A.;
RT   "20 years of human pluripotent stem cell research: it all started with
RT   five lines.";
RL   Cell Stem Cell 23:644-648(2018).
//
RX   PubMed=35805069; DOI=10.3390/cells11131984; PMCID=PMC9265327;
RA   Molina-Ruiz F.J., Introna C., Bombau G., Galofre M., Canals J.M.;
RT   "Standardization of cell culture conditions and routine genomic
RT   screening under a quality management system leads to reduced genomic
RT   instability in hPSCs.";
RL   Cells 11:1984.1-1984.25(2022).
//